Abstract. Infectious bursal disease virus (IBDV), family Birnaviradae, is the etiologic agent of a commercially important, globally distributed, contagious, immunosuppressive disease of young chickens. A restriction enzyme-compatible ssRNA internal control was developed for an IBDV reverse transcription/polymerase chain reaction-restriction fragment length polymorphism (RT/PCR-RFLP) diagnostic assay. An 841-bp bacteriophagelambda DNA fragment was directionally ligated to 3Ј and 5Ј oligonucleotide linkers containing the IBDV RT/ PCR target primer sequences. A pGEM-3Zf (ϩ) transcription vector containing the internal control construct was used in an in vitro transcription reaction to produce ssRNA. After RT and PCR amplification, the transcripts produced an 882-bp cDNA product, larger than, co-amplifiable with, and free of the restriction sites used to prepare RFLP patterns of the 743-bp IBDV cDNA target product. The limit of detection of the transcripts in the RT/PCR test is 3.2 femtograms. With the internal control, a test inhibition rate of 7.7% (20/261) was determined for the IBDV RT/PCR assay. By identifying inhibited tests, the assay was improved through a reduction in the number of false-negative results.Infectious bursal disease virus (IBDV), a member of the Birnaviridae family, 3 is the causative agent of an economically important immunosuppressive disease of young chickens. The use of the reverse transcription/ polymerase chain reaction (RT/PCR) to detect IBDV in field and laboratory samples has been reported previously. 7,11,12,17,18,21 A RT/PCR diagnostic assay for IBDV was developed in this laboratory. 8 In the assay, 743-bp RT/PCR products containing the coding sequence for a portion of the IBDV structural protein VP2 are digested with the restriction enzymes (REs) BstNI and MboI to yield a variety of restriction fragment length polymorphism (RFLP) patterns. These patterns are used to place field, vaccine, and previously characterized laboratory strains of the virus into different molecular groups. 7,9 The application of PCR and RT/PCR methodologies in research and diagnostic testing has become commonplace since the first description of the PCR by Saiki. 16 Although these methods have led to the development of powerful diagnostic assays with respect to observed and theoretical sensitivity and specificity, they are also quite complex. A number of factors can influence the success or failure of an indi- However, the performance of individual PCR and RT/ PCR tests can vary from 1 sample to another because of the presence of inhibitors. 4,15,19 The tissue type and the quality of extracted RNA have been noted to affect test performance. As an aide in monitoring reaction performance, and to identify the occurrence of false-negative tests due to reaction inhibition or technical errors in test preparation, a RE assay-compatible IC reagent was developed. The production and use of this IC is described.